§ 866.1645. Fully automated short-term incubation cycle antimicrobial susceptibility system.
100 words·~1 min read·
/us/cfr/t21/s§ 866.1645·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)Identification. A fully automated short-term incubation cycle antimicrobial susceptibility system is a device that incorporates concentrations of antimicrobial agents into a system for the purpose of determining in vitro susceptibility of bacterial pathogens isolated from clinical specimens. Test results obtained from short-term (less than 16 hours) incubation are used to determine the antimicrobial agent of choice to treat bacterial diseases.
(b)Classification. Class II (special controls). The special control for this device is FDA's guidance document entitled “Class II Special Controls Guidance Document: Antimicrobial Susceptibility Test
(AST)Systems; Guidance for Industry and FDA.” [68 FR 5827, Feb. 5, 2003]